AN301970L
Recombinant CLEC2D Monoclonal Antibody
Größe
£252.90
War £281.00
- SKU:
- AN301970L
- Zusätzliche Namen:
- LLT,CLEC2D,CLAX,LLT1,OCIL,C type lectin related f,C type lectin superfamily 2,CLC2D,CLEC2D protein,Clec2d5,C-type lectin domain family 2 member D,L LT1,Lectin like NK cell receptor,Lectin like transcript 1,Lectin-like NK cell receptor,Lectin-like transcript 1,LLT-1,member D,Osteoclast inhibitory lectin
- Anwendung:
- WB
- Konzentration:
- 1 mg/ml
- Aufreinigung:
- Protein A Purified
- Lagerbedingungen:
- -20[o]C Avoid freeze/thaw cycles.
- Hersteller:
- Elabscience
- Host:
- Rabbit
- Reaktivitäten:
- Human
- Buffer:
- PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant.
- Immunogen:
- Recombinant human CLEC2D fragment
- Klon:
- A686
- Uniprot:
- Q9UHP7
- Synonyme:
- C-type lectin domain family 2 member D;C-type lectin related f;C-type lectin superfamily 2, member D;CLAX;lectin-like NK cell receptor;lectin-like transcript 1;LLT-1;LLT1;OCIL;osteoclast inhibitory lectin
- Weitere Details:
- C-type lectin domain family 2 member D (CLEC2D), also known as lectin-like transcript 1 (LLT1) and osteoclast inhibitory lectin (OCIL), is a type II transmembrane C-type lectin receptor primarily expressed upon immune cell activation in T cells, B cells, NK cells, and plasmacytoid and monocyte-derived dendritic cells. CLEC2D interacts with NKR-P1A (KLRB1, CD161) on NK cells and some subsets of T cells, inhibiting NK cell cytotoxicity while alternatively inducing proliferation and IFNG Gamma production in T cells. CLEC2D is also expressed by osteoblasts, inhibiting osteoclast formation and bone resorption.
- Versandbedingungen:
- Blue Ice